Droia Oncology Ventures raises second fund of EUR 150 million
10 déc. 2018 12h53 HE
|
Droia Oncology Ventures
Droia Oncology Ventures raises second fund of EUR 150 million December 10th 2018: Droia, a specialist investor focused on oncology therapeutics, announced the closing of Droia II, its second fund, at...
Tusk Therapeutics to be acquired by Roche
28 sept. 2018 01h30 HE
|
Tusk Therapeutics Ltd
Tusk Therapeutics to be acquired by Roche Stevenage, United Kingdom – September 28th 2018: Tusk Therapeutics Ltd (“Tusk”) was today acquired by Roche. Tusk has developed an antibody with a novel...